Mini Review
Published on 05 Oct 2021
Old Problem, New Concerns: Hypercortisolemia in the Time of COVID-19
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.711612
- 5,253 views
- 13 citations
Type at least 3 characters
454 articles
Systematic Review
Published on 01 Oct 2021
Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.735655
- 4,943 views
- 10 citations
Original Research
Published on 01 Oct 2021
Cushing’s Disease: Assessment of Early Cardiovascular Hemodynamic Dysfunction With Impedance Cardiography
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.751743
- 5,177 views
- 12 citations
Original Research
Published on 30 Sep 2021
Suprasellar Mature Cystic Teratoma Mimicking Rathke’s Cleft Cyst: A Case Report and Systematic Review of the Literature
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.731088
- 3,068 views
- 5 citations
Original Research
Published on 30 Sep 2021
Prediction of the Recurrence of Non-Functioning Pituitary Adenomas Using Preoperative Supra-Intra Sellar Volume and Tumor-Carotid Distance
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.748997
- 5,001 views
- 8 citations
Original Research
Published on 29 Sep 2021
Molecular Profile of a Pituitary Rhabdomyosarcoma Arising From a Pituitary Macroadenoma: A Case Report
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.752361
- 2,652 views
- 4 citations
Original Research
Published on 24 Sep 2021
Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.737947
- 1,801 views
- 6 citations
Systematic Review
Published on 17 Sep 2021
Effectiveness of Medical Treatment of Cushing’s Disease: A Systematic Review and Meta-Analysis
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.732240
- 10,593 views
- 19 citations
Review
Published on 14 Sep 2021
Management of Patients With Glucocorticoid-Related Diseases and COVID-19
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.705214
- 10,144 views
- 18 citations
Original Research
Published on 13 Sep 2021
Whole Exome Sequencing Uncovered the Genetic Architecture of Growth Hormone Deficiency Patients
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.711991
- 6,043 views
- 7 citations
Original Research
Published on 02 Sep 2021
An Optimized Pathway for the Differential Diagnosis of ACTH-Dependent Cushing’s Syndrome Based on Low-Dose Dexamethasone Suppression Test
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.720823
- 5,180 views
- 8 citations
Case Report
Published on 26 Jul 2021
Case Report: Identification of Potential Prognosis-Related TP53 Mutation and BCL6-LPP Fusion in Primary Pituitary Lymphoma by Next Generation Sequencing: Two Cases
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.673908
- 3,419 views
- 6 citations
Case Report
Published on 14 Jul 2021
Pituitary Metastasis of Lung Neuroendocrine Carcinoma Mimicking Pituitary Adenoma:Case Report and Literature Review
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.678947
- 5,300 views
- 8 citations
Clinical Trial
Published on 14 Jul 2021
Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.662865
- 20,453 views
- 46 citations
Original Research
Published on 12 Jul 2021
Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.684055
- 2,735 views
- 7 citations
Original Research
Published on 05 Jul 2021
Phosphorylated EGFR (pEGFR T693) as a Novel Predictor of Recurrence in Non-Functioning Pituitary Adenomas
in Pituitary Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2021.708111
- 4,017 views
- 9 citations